Skip to main content

Table 1 Laboratory results at presentation and at 1ā€‰year of follow up

From: Bartonella endocarditis and diffuse crescentic proliferative glomerulonephritis with a full-house pattern of immune complex deposition

Ā 

Presentation

Follow-up

Reference Range

Hemoglobin (g/dl)

7.7

13

12.0ā€“15.0

WBC (Ɨā€‰109/L)

7.2

8.6

3.6ā€“10.6

Platelet (Ɨ109/L)

192

387

150ā€“450

BUN (mg/dl)

64

19

5.0ā€“20.0

Creatinine (mg/dl)

2.5

0.68

0.4ā€“0.9

eGFR(ml/min/1.73m2)

27.6

88

ā‰„ 90

Total protein (g/dl)

6

NA

6.7ā€“8.2

Albumin (g/dl)

2.7

4.5

3.5ā€“4.7

LDH (units/L)

365

NA

140ā€“270

ALT (uints/L)

3

NA

7ā€“52

ESR (mm/hr)

32

NA

0ā€“20

CRP (mg/dl)

5.2

NA

ā‰¤ 1.0

Complement C3 (mg/dl)

34

NA

65ā€“180

Complement C4 (mg/dl)

10

NA

13ā€“52

Anti-nuclear antibody

<ā€‰ 1:80

NA

<ā€‰1:80

Anti-dsDNA antibody (IU/ml)

0.8

NA

0ā€“9.9

Smith antibody

negative

NA

negative

anti-RNP antibodies

negative

NA

negative

cardiolipin antiobody (mPL unit)

negative

NA

0ā€“9.9

ANCA

negative

NA

negative

Anti-MPO (AU/ml)

0

NA

0ā€“19

Anti-PR3 (AU/ml)

0

NA

0ā€“19

Urine protein (mg/dl)

500

100

0ā€“15

Urine protein creatinin ratio

12.8

0.98

<ā€‰ 0.2

Urine RBC (/HPF)

>ā€‰ 100

3ā€“5

0ā€“2

Urine WBC (/HPF)

51ā€“100

0ā€“5

0ā€“5

  1. Abbreviations: ALT alanine aminotransferease, ANCA antineutrophil cytoplasmic antibodies, Anti-MPO anti-myeloperoxidase antibodies, Anti-PR3 anti-proteinase-3 antibodies, Anti-RNP antinuclear ribonucleoprotein antibodies, BUN blood urea nitrogen, CRP C-reactive protein, ESR Eerythrocyte sedimentation rate, eGFR estimated glomerular filtration rate, HPF high power field, LDH Lactate dehydrogenase, RBC red blood cells, WBC white blood cells